Maternal Smoking and Metabolic Health Biomarkers in Newborns.
Maternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4658089?pdf=render |
id |
doaj-c0b086b9ce67406b8f8ad11cddef70bd |
---|---|
record_format |
Article |
spelling |
doaj-c0b086b9ce67406b8f8ad11cddef70bd2020-11-25T01:51:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014366010.1371/journal.pone.0143660Maternal Smoking and Metabolic Health Biomarkers in Newborns.Fang FangZhong-Cheng LuoAnissa DejemliEdgard DelvinJun ZhangMaternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses/newborns.In a prospective singleton pregnancy cohort (n = 248), we compared metabolic health biomarkers in the newborns of smoking and non-smoking mothers. Outcomes included cord plasma insulin, proinsulin, insulin-like growth factor I (IGF-I), IGF-II, leptin and adiponectin concentrations, glucose-to-insulin ratio (an indicator of insulin sensitivity) and proinsulin-to-insulin ratio (an indicator of β-cell function).Independent of maternal (glucose tolerance, age, ethnicity, parity, education, body mass index, alcohol use) and infant (sex, gestational age, birth weight z score, mode of delivery, cord blood glucose concentration) characteristics, the newborns of smoking mothers had lower IGF-I concentrations (mean: 6.7 vs. 8.4 nmol/L, adjusted p = 0.006), and marginally higher proinsulin-to-insulin ratios (0.94 vs. 0.72, adjusted p = 0.06) than the newborns of non-smoking mothers. Cord plasma insulin, proinsulin, IGF-II, leptin and adiponectin concentrations and glucose-to-insulin ratios were similar in the newborns of smoking and non-smoking mothers.Maternal smoking was associated with decreased fetal IGF-I levels, and borderline lower fetal β-cell function. Larger cohort studies are required to confirm the latter finding. The preliminary findings prompt the hypothesis that these early life metabolic changes may be involved in the impact of maternal smoking on future risk of metabolic syndrome related disorders in the offspring.http://europepmc.org/articles/PMC4658089?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fang Fang Zhong-Cheng Luo Anissa Dejemli Edgard Delvin Jun Zhang |
spellingShingle |
Fang Fang Zhong-Cheng Luo Anissa Dejemli Edgard Delvin Jun Zhang Maternal Smoking and Metabolic Health Biomarkers in Newborns. PLoS ONE |
author_facet |
Fang Fang Zhong-Cheng Luo Anissa Dejemli Edgard Delvin Jun Zhang |
author_sort |
Fang Fang |
title |
Maternal Smoking and Metabolic Health Biomarkers in Newborns. |
title_short |
Maternal Smoking and Metabolic Health Biomarkers in Newborns. |
title_full |
Maternal Smoking and Metabolic Health Biomarkers in Newborns. |
title_fullStr |
Maternal Smoking and Metabolic Health Biomarkers in Newborns. |
title_full_unstemmed |
Maternal Smoking and Metabolic Health Biomarkers in Newborns. |
title_sort |
maternal smoking and metabolic health biomarkers in newborns. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Maternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses/newborns.In a prospective singleton pregnancy cohort (n = 248), we compared metabolic health biomarkers in the newborns of smoking and non-smoking mothers. Outcomes included cord plasma insulin, proinsulin, insulin-like growth factor I (IGF-I), IGF-II, leptin and adiponectin concentrations, glucose-to-insulin ratio (an indicator of insulin sensitivity) and proinsulin-to-insulin ratio (an indicator of β-cell function).Independent of maternal (glucose tolerance, age, ethnicity, parity, education, body mass index, alcohol use) and infant (sex, gestational age, birth weight z score, mode of delivery, cord blood glucose concentration) characteristics, the newborns of smoking mothers had lower IGF-I concentrations (mean: 6.7 vs. 8.4 nmol/L, adjusted p = 0.006), and marginally higher proinsulin-to-insulin ratios (0.94 vs. 0.72, adjusted p = 0.06) than the newborns of non-smoking mothers. Cord plasma insulin, proinsulin, IGF-II, leptin and adiponectin concentrations and glucose-to-insulin ratios were similar in the newborns of smoking and non-smoking mothers.Maternal smoking was associated with decreased fetal IGF-I levels, and borderline lower fetal β-cell function. Larger cohort studies are required to confirm the latter finding. The preliminary findings prompt the hypothesis that these early life metabolic changes may be involved in the impact of maternal smoking on future risk of metabolic syndrome related disorders in the offspring. |
url |
http://europepmc.org/articles/PMC4658089?pdf=render |
work_keys_str_mv |
AT fangfang maternalsmokingandmetabolichealthbiomarkersinnewborns AT zhongchengluo maternalsmokingandmetabolichealthbiomarkersinnewborns AT anissadejemli maternalsmokingandmetabolichealthbiomarkersinnewborns AT edgarddelvin maternalsmokingandmetabolichealthbiomarkersinnewborns AT junzhang maternalsmokingandmetabolichealthbiomarkersinnewborns |
_version_ |
1724997874093129728 |